Press release
Savara Inc. (NASDAQ: SVRA) Investor Alert: Deadline in Lawsuit on November 7, 2025
A Deadline is coming up on November 7, 2025 in the lawsuit for certain investors in Savara Inc. (NASDAQ: SVRA).
Investors who purchased shares of Savara Inc. (NASDAQ: SVRA) have certain options and there are strict and short deadlines running. Deadline: November 7, 2025. Savara Inc. (NASDAQ: SVRA) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the complaint filed in the U.S. District Court for the Eastern District of Pennsylvania the plaintiff alleges on behalf of purchasers of Savara Inc. (NASDAQ: SVRA) common shares between March 7, 2024 and May 23, 2025, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between March 7, 2024 and May 23, 2025, the Defendants failed to disclose to investors that the MOLBREEVI BLA lacked sufficient information regarding MOLBREEVI's chemistry, manufacturing, and/or controls, that accordingly, the FDA was unlikely to approve the MOLBREEVI BLA in its current form, that the foregoing made it unlikely that Savara would complete its submission of the MOLBREEVI BLA within the timeframe it had represented to investors, that the delay in MOLBREEVI's regulatory approval increased the likelihood that the Company would need to raise additional capital, and that as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.
Those who purchased shares of Savara Inc. (NASDAQ: SVRA) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Savara Inc. (NASDAQ: SVRA) Investor Alert: Deadline in Lawsuit on November 7, 2025 here
News-ID: 4245738 • Views: …
More Releases from Shareholders Foundation, Inc.
Lawsuit filed for Investors who lost money with shares of Primo Brands Corporati …
An investor, who purchased shares of Primo Brands Corporation (NYSE: PRMB), filed a lawsuit over alleged violations of Federal Securities Laws in connection with certain allegedly false and misleading statements.
Investors who purchased a significant amount of shares of Primo Water (formerly NYSE: PRMW) between June 17, 2024 through November 8, 2024, and/or purchased a significant amount of shares Primo Brands Corporation (NYSE: PRMB) between November 11, 2024 through November 6,…
Lawsuit Alert: Investors who lost a substantial amount with Telix Pharmaceutical …
An investor, who purchased shares of Telix Pharmaceuticals Limited (NASDAQ: TLX), filed a lawsuit in the U.S. over alleged violations of Federal Securities Laws by Telix Pharmaceuticals Limited in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Telix Pharmaceuticals Limited (NASDAQ: TLX) have certain options and for certain investors are short and strict deadlines running. Deadline: January 9, 2026. NASDAQ: TLX investors should contact the Shareholders…
Investigation announced for Long-Term Investors in shares of Savara Inc. (NASDAQ …
An investigation was announced for long-term investors in shares of Savara Inc. (NASDAQ: SVRA) concerning potential breaches of fiduciary duties by certain directors of Savara Inc.
Investors who are current long term investors in Savara Inc. (NASDAQ: SVRA) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: SVRA stocks…
Lawsuit filed for Investors who lost money with shares of Inspire Medical System …
An investor, who purchased shares of Inspire Medical Systems, Inc. (NYSE: INSP), filed a lawsuit over alleged violations of Federal Securities Laws by Inspire Medical Systems, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Inspire Medical Systems, Inc. (NYSE: INSP) have certain options and for certain investors are short and strict deadlines running. Deadline: January 5, 2026. NYSE: INSP investors should contact the Shareholders…
More Releases for Savara
Lawsuit filed for Investors who lost money with shares of Savara Inc. (NASDAQ: S …
An investor, who purchased shares of Savara Inc. (NASDAQ: SVRA), filed a lawsuit over alleged violations of Federal Securities Laws by Savara Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Savara Inc. (NASDAQ: SVRA) have certain options and for certain investors are short and strict deadlines running. Deadline: November 7, 2025. NASDAQ: SVRA investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)…
Autoimmune Pulmonary Alveolar Proteinosis Market to Expand Significantly by 2032 …
The Key Autoimmune Pulmonary Alveolar Proteinosis Companies in the market include - Savara Inc., and others.
DelveInsight's "Autoimmune Pulmonary Alveolar Proteinosis Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Autoimmune Pulmonary Alveolar Proteinosis, historical and forecasted epidemiology as well as the Autoimmune Pulmonary Alveolar Proteinosis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the…
Autoimmune Pulmonary Alveolar Proteinosis Market | Savara Pharmaceuticals, Bridg …
DelveInsight's "Autoimmune Pulmonary Alveolar Proteinosis Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of Autoimmune Pulmonary Alveolar Proteinosis, historical and forecasted epidemiology as well as the Autoimmune Pulmonary Alveolar Proteinosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Autoimmune Pulmonary Alveolar Proteinosis market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and…
Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Market to Observe Impressive Gr …
DelveInsight's "Autoimmune Pulmonary Alveolar Proteinosis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Autoimmune Pulmonary Alveolar Proteinosis, historical and forecasted epidemiology as well as the Autoimmune Pulmonary Alveolar Proteinosis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Autoimmune Pulmonary Alveolar Proteinosis market outlook, drug uptake, treatment scenario and epidemiology trends, Click…
Autoimmune Pulmonary Alveolar Proteinosis Market | Savara Pharmaceuticals, Bridg …
DelveInsight's "Autoimmune Pulmonary Alveolar Proteinosis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Autoimmune Pulmonary Alveolar Proteinosis, historical and forecasted epidemiology as well as the Autoimmune Pulmonary Alveolar Proteinosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Autoimmune Pulmonary Alveolar Proteinosis market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and…
Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Market to Observe Impressive Gr …
DelveInsight's "Autoimmune Pulmonary Alveolar Proteinosis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Autoimmune Pulmonary Alveolar Proteinosis, historical and forecasted epidemiology as well as the Autoimmune Pulmonary Alveolar Proteinosis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Autoimmune Pulmonary Alveolar Proteinosis market outlook, drug uptake, treatment scenario and epidemiology trends, Click…
